Pharmaceutical companies will now be required to disclose price of drugs in TV ads

From Joe Williams:

Pharmaceutical firms will now be required to disclose the list price of treatments if the cost is higher than $35 per monthly prescription, according to a new rule finalized on Wednesday by the Trump administration.

NYSE:XPH May 8, 2019 3:18pm

Weak Sector Earnings Dragging Pharmaceutical ETFs Down (XPH)

From Zacks: Total earnings for 83.1% of the total healthcare market capitalization are up 14.7% on revenue growth of 8.1%. The growth rates seem unimpressive when compared with some of the other sectors. Earnings and revenue beat ratios of 88.9% and 75%, respectively, are also not great either.
NYSE:XPH May 7, 2018 6:56am

Profit From The Massive Pharma Deals With This ETF [Valeant Pharmaceuticals Intl Inc, SPDR S&P Pharmaceuticals (ETF)]

money and investingKyle Anderson:  Valeant Pharmaceuticals International Inc. (NYSE:VRX) confirmed its $1 billion acquisition of Sprout Pharmaceuticals Inc. today (Thursday).
NYSE:XPH August 27, 2015 11:42am

A Massive Trend Of Pharmaceutical Mergers [Shire PLC (ADR), Baxalta Inc, Allergan PLC]

biotechKyle Anderson: Another possible deal between two of the world's top pharmaceutical companies was announced this week when Shire Plc. (NASDAQ:SHPG) made an unsolicited offer of $30.6 billion for Baxalta Inc. (NYSE:BXLT).
NYSE:XPH August 13, 2015 1:04pm

Pharma’s Record Setting First Quarter [Actavis plc, Allergan, Inc., Eli Lilly and Co, Novartis AG (ADR), AbbVie Inc]

biotechKyle Anderson: The pharmaceutical industry saw record-setting M&A activity in the first quarter of 2015.
NYSE:XPH May 12, 2015 12:37pm

A Beaten-Up Pharma With a Big Upside [The Medicines Company(NASDAQ:MDCO), Pfizer Inc.(NYSE:PFE), Merck & Co., Inc.(NYSE:MRK)]

biotechnologyThe Medicines Company(NASDAQ:MDCO) has had a really tough first half of 2014, and the stock price shows it. When one of its drugs did not receive approval from regulators and a court decision concerning one of its drugs going generic went against the company, the stock dropped
NYSE:IHE August 19, 2014 10:15am

ETF Winners From Earnings Season [First Trust ISE Revere Natural Gas (ETF), SPDR S&P Pharmaceuticals (ETF)]

new etfsSweta Killa: The Q1 2014 earnings season is currently in the halfway mark and the growth picture looks uninspiring, with lack of top-line surprises and weak management guidance for the second quarter.
NYSE:FCG May 7, 2014 1:09pm

Top Pharmaceutical ETFs To Consider [Biogen Idec Inc, SPDR S&P Pharmaceuticals (ETF), Health Care SPDR (ETF)]

healthcare1After the incredible surge in 2013, the healthcare sector is no doubt crushing the overall market this year too. This is largely thanks to the bullish trend in both the pharma and biotech segments
NYSE:IHE March 16, 2014 4:04pm

Top Ranked Healthcare ETF In Focus [SPDR S&P Pharmaceuticals (ETF), SPDR S&P Biotech (ETF)]

in focus spotlightThe U.S. health care sector was a star performer in 2013. It remained a favorite among investors in spite of the uncertain economic climate worldwide. New product launches, solid earnings results and increasing merger & acquisition activities were the major drivers for this sector.
NASDAQ:IBB February 14, 2014 4:46pm

Quick Investor Guide To Pharmaceutical ETFs

healthcare-etfsWith the year coming to an end, the worst of the patent cliff faced by the pharmaceutical sector in recent times is over. Although genericization will continue, the major patent expiries are over and done with.
NYSE:IHE December 26, 2013 2:09pm

3 ETF Winners From November

new etfsNovember continued 2013’s strong rally, as investors breezed by concerns over political issues to push stocks higher. Both the major U.S. benchmarks – Dow Jones and the S&P 500 – broke milestones with the DJIA hitting 16,000 and S&P 500 crossing 1,800
NYSE:IAI December 4, 2013 12:05pm

3 Pharmaceutical ETFs Leading The Healthcare Sector

healthcare1The pharmaceutical industry has been performing remarkably well this year after emerging relatively unscathed from one of the biggest patent cliffs in recent times.
NYSE:IHE November 26, 2013 12:11am

How To Play The Bullish Trend In Healthcare With ETFs

healthcare-etfsWhile there have been a series of volatility-inducing events in the U.S. starting from the Fed’s ‘Taper Talk’ and then the tussle between the Republicans and the Democrats, investors have still remained relatively bullish and have put capital
NYSE:BBH November 1, 2013 1:57pm

Expect A Pullback In The SPDR S&P Pharmaceuticals ETF (XPH)

sellbuyMorpheus Trading: SPDR S&P Pharmaceuticals (NYSEARCA:XPH) has been leading the market higher all year. So far, little has changed because $XPH continues to trend higher above its 50-day moving average.
NYSE:IYR October 22, 2013 10:23am

Get Free Updates

Join over 50,000 investors who get the latest news from!

Most Popular

From Our Partners

Explore More from

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again! respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories